Guardian Pharmacy Services, Inc.
GRDN · NYSE
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Revenue | $1 | $1 | $1 | $1 |
| % Growth | 17.4% | 15.1% | 14.8% | – |
| Cost of Goods Sold | $1 | $1 | $1 | $1 |
| Gross Profit | $0 | $0 | $0 | $0 |
| % Margin | 19.9% | 19.9% | 20.4% | 20.4% |
| R&D Expenses | $0 | $0 | $0 | $0 |
| G&A Expenses | $0 | $0 | -$0 | $0 |
| SG&A Expenses | $0 | $0 | $0 | $0 |
| Sales & Mktg Exp. | $0 | $0 | $0 | $0 |
| Other Operating Expenses | $0 | $0 | $0 | $0 |
| Operating Expenses | $0 | $0 | $0 | $0 |
| Operating Income | -$0 | $0 | $0 | $0 |
| % Margin | -5.1% | 3.9% | 5.7% | 3.8% |
| Other Income/Exp. Net | -$0 | -$0 | -$0 | -$0 |
| Pre-Tax Income | -$0 | $0 | $0 | $0 |
| Tax Expense | $0 | $0 | $0 | $0 |
| Net Income | -$0 | $0 | $0 | $0 |
| % Margin | -7.1% | 2.3% | 3.9% | 2.1% |
| EPS | -1.77 | 0.39 | 0.58 | 0.27 |
| % Growth | -553.8% | -32.8% | 114.8% | – |
| EPS Diluted | -1.77 | 0.39 | 0.58 | 0.27 |
| Weighted Avg Shares Out | 0 | 0 | 0 | 0 |
| Weighted Avg Shares Out Dil | 0 | 0 | 0 | 0 |
| Supplemental Information | – | – | – | – |
| Interest Income | $0 | $0 | $0 | $0 |
| Interest Expense | $0 | $0 | $0 | $0 |
| Depreciation & Amortization | $0 | $0 | $0 | $0 |
| EBITDA | -$0 | $0 | $0 | $0 |
| % Margin | -3.5% | 5.6% | 7.5% | 5.9% |